Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
about
Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidenceTibolone: the way to beat many a postmenopausal ailmentsSex hormones and gene expression signatures in peripheral blood from postmenopausal women - the NOWAC postgenome study.The role of androgens in hormone replacement therapy.Loss of libido in postmenopausal women.Skin climacteric aging and hormone replacement therapy.Beneficial effect of tibolone on mood, cognition, well-being, and sexuality in menopausal womenDefects of steroidogenesis.Drugs for the treatment of menopausal symptoms.Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.Breast cancer treatment and sulfotransferase.Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.Hormone replacement therapy with tibolone: effects on sexual functioning in postmenopausal women.Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women.Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction.Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.Historical milestones in the development of tibolone (Livial®).Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women.Sex hormone-binding globulin and antithrombin III activity in women with oral ultra-low-dose estradiol.
P2860
Q24647700-31D90867-65A6-4D12-AF19-384653AFB3A7Q28274518-5E880A02-6A3A-4620-B20B-1D1440EDC5CDQ33858917-B4B55C9A-BCBB-49CE-9D88-0E50A3D571EAQ36249910-F56D3F21-421F-4060-B646-071A6DD208F6Q36603605-C6A269E4-16EE-4206-BC70-12606CD95AFCQ36686101-F5228F87-5B5A-4FBE-853B-DD4731D582D8Q37165719-31009A79-BC8B-4983-92F2-C755EBA4B2D9Q37700091-3FC82991-CF18-494D-B366-EAD2250F8010Q37735189-A418B197-F7DC-4CC6-AA96-56D4DBB81924Q37768413-5516431A-5B96-4216-AE8E-82DC96E1C4E0Q38353775-4B03A40A-41BE-4432-946C-9790EE8883A5Q43225739-E4DADE59-5879-4857-828B-FE304621D564Q44110987-B479294A-1851-4288-9D08-EBC8BE55411EQ44115504-C5F4074E-1F2D-4180-8795-3157237DE293Q46141973-65205798-9C26-40A9-BE53-6AB6105E484BQ46600428-CDC1264E-16BC-4646-8453-FE4C9D26F5D5Q48586031-06E70391-FE72-4EF3-BF2C-DDD3681B6709Q51777872-EF7F6094-7FF5-461F-97F4-C577BCC62616Q52699902-4145F921-EBE6-436B-B0F5-9B439987CBB2
P2860
Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Differential effects on the an ...... e acetate replacement therapy.
@ast
Differential effects on the an ...... e acetate replacement therapy.
@en
type
label
Differential effects on the an ...... e acetate replacement therapy.
@ast
Differential effects on the an ...... e acetate replacement therapy.
@en
prefLabel
Differential effects on the an ...... e acetate replacement therapy.
@ast
Differential effects on the an ...... e acetate replacement therapy.
@en
P2093
P1476
Differential effects on the an ...... e acetate replacement therapy.
@en
P2093
Coelingh Bennink HJ
Holzgreve W
P304
P356
10.1016/S0015-0282(00)01768-4
P407
P577
2001-03-01T00:00:00Z